Press Contact

If you would like to find out more about Abiomed® and the Impella® heart pumps, or if you have any questions, please do not hesitate to contact us.


Dr. Sebastian Heindrichs

Associate Director European Communications
Neuenhofer Weg 3 | 52074 Aachen,  Germany
E-Mail: sheindrichs(at)
Phone: +49 (0)151 7447 2278

Press Releases

July 30, 2020

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump
PDF Download

July 1, 2020

Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist
PDF Download

June 16, 2020

Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes
PDF Download

June 5, 2020

FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump
PDF Download

May 19, 2020

PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI
PDF Download

April 29, 2020

Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients
PDF Download

May 21, 2019

National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery

PDF Download

April 4, 2019

Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval

PDF Download